Area of research
Epidemiology · Infectious Diseases
Research interest
Research interests include Fungal Infections and Studies, Antifungal resistance and susceptibility, Nail Diseases and Treatments, and HIV/AIDS Research and Interventions.
Causes of hospitalisation among people living with HIV worldwide, 2014–23: a systematic review and meta-analysis
Recent Antiretroviral Therapy Initiation Is Associated With Increased Mortality Risk in Human Immunodeficiency Virus–associated Cryptococcal Meningitis: An Analysis of Clinical Trial Data From Africa
Reducing HIV incidence and mortality: two sides of the same coin in the approach to ending AIDS
Personalised risk-prediction tools for cryptococcal meningitis mortality to guide treatment stratification in sub-Saharan Africa: a prognostic modelling study based on pooled analysis of two randomised controlled trials
Ethical issues surrounding the implementation of long-acting injectable antiretroviral therapy in sub-Saharan Africa
Diagnostic accuracy of the <scp>WHO</scp> clinical staging system for detection of immunologically defined advanced <scp>HIV</scp> disease: A systematic review and meta‐analysis
Interventions to Support People With HIV Following Hospital Discharge: A Systematic Review
Efficacy and Safety of Long-acting Injectable Cabotegravir and Rilpivirine in Improving HIV-1 Control in sub-Saharan Africa: Protocol for a Phase 3b Open-Label Randomized Controlled Trial (IMPALA)
Epstein–Barr virus and cytomegalovirus co-infections and mortality risk in patients with HIV-associated cryptococcal meningitis: a post-hoc analysis of a prospective nested cohort in the AMBITION-cm randomised controlled trial
Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM
Development and validation of quantitative PCR assays for HIV-associated cryptococcal meningitis in sub-Saharan Africa: a diagnostic accuracy study
Tracking Cryptococcal Meningitis to Monitor HIV Program Success During the Treat All Era: An Analysis of National Data in Botswana
Implementation of Single High-dose Liposomal Amphotericin B Based Induction Therapy for Treatment of HIV-associated Cryptococcal Meningitis in Uganda: A Comparative Prospective Cohort Study
Two-drug regimens for the treatment of HIV in Africa
Reduction in mortality from HIV-related CNS infections in routine care in Africa (DREAMM): a before-and-after, implementation study
Population pharmacokinetics and CSF penetration of flucytosine in adults with HIV-associated cryptococcal meningoencephalitis
Pathways to care with HIV-associated cryptococcal meningitis in Botswana and Uganda: Findings from a qualitative methods study
Clinical research for life-threatening illnesses requiring emergency hospitalisation: a critical interpretive synthesis of qualitative data related to the experience of participants and their caregivers
Translating evidence into global impact: lessons for HIV research and policy development from the AMBITION trial
Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis
LSTM Online Archive (Liverpool School of Tropical Medicine) 2022cited by 219position: middle
Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial
Laboratory Evaluation of the VISITECT Advanced Disease Semiquantitative Point-of-Care CD4 Test
Decision making in a clinical trial for a life-threatening illness: Therapeutic expectation, not misconception
Association of Hyponatremia on Mortality in Cryptococcal Meningitis: A Prospective Cohort
How Applicable Is the Single-Dose AMBITION Regimen for Human Immunodeficiency Virus–Associated Cryptococcal Meningitis to High-Income Settings?
The acceptability of the AMBITION-cm treatment regimen for HIV-associated cryptococcal meningitis: Findings from a qualitative methods study of participants and researchers in Botswana and Uganda
Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitis
Single-Dose Amphotericin B for Cryptococcal Meningitis
Reversal of CSF HIV-1 Escape during Treatment of HIV-Associated Cryptococcal Meningitis in Botswana